BCG: Myths, realities, and the need for alternative vaccine strategies

Tuberculosis

Volumn 92, Issue 3, 2012, Pages 283-288

  McShane, Helen ^a   Jacobs, William R ^b   Fine, Paul E ^c   Reed, Steven G ^d   McMurray, David N ^e   Behr, Marcel ^f   Williams, Ann ^g   Orme, Ian M ^h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h Department of Ecosystem Science and Sustainability   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULIN;

BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELLULAR IMMUNITY; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG EFFICACY; DRUG SCREENING; ENVIRONMENTAL EXPOSURE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; LETTER; LUNG DISEASE; LUNG TUBERCULOSIS; MEMORY T LYMPHOCYTE; META ANALYSIS (TOPIC); MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; STUDY DESIGN; TUBERCULOUS MENINGITIS; VACCINATION; WORKSHOP;

ANIMALS; BCG VACCINE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84859515227     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.12.003     Document Type: Letter

References (0)